MENU
KPTI
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Karyopharm Therapeutics (KPTI) Ownership - Who owns Karyopharm Therapeutics?
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company pioneering novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
325
Web
https://www.karyopharm.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
57.99M
P/E Ratio
N/A
Total Cash
43.04M
Projected Growth
N/A
Total Debt
194.26M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
5.11
Total Debt/Equity
N/A
Revenue/Share
17.18 USD as % of share price
Fundamentals
KPTI
Capitalization
58M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
43M
Total Cash/Share
5.11
Total Debt
194M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
17.18%
Revenue
N/A
ROE
N/A
Book Value
-159.65M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
13K
Current Ratio
3.00
Current Revenue Per Employee
119332.30
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
96.65
Revenue To Assets
N/A
Shares Held By Institutions
N/A
Shares Outstanding - Current
8.42M
Total Liabilities
349M
Total Volume MTD
N/A
Value
1
Gain YTD
-37.207
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of novel drugs for the treatment of cancer, inflammation and other diseases related to cell proliferation
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
85 Wells Avenue
Phone
+1 617 658-0600
Employees
325
Web
https://www.karyopharm.com